Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee

A Multicenter, Prospective Observational Study to Evaluate the Injection Site Reactions of Synovian® Inj. in Patients With Osteoarthritis in the Knee

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04369261

Enrollment

1949

Registered

2020-04-30

Start date

2018-03-09

Completion date

2019-08-08

Last updated

2020-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis in the Knee

Brief summary

This is an observational study to evaluate the injection site reactions of Synovian® Inj. in patients with osteoarthritis in the knee

Interventions

DRUGSynovian®

Synovian® Inj.

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult male or female patient of over 19 years of age * A patient diagnosed with knee osteoarthritis * A patient who has been informed of the purpose, method of the study and signed the written informed consent form.

Exclusion criteria

* A patient who shows hypersensitive reaction to the Synovian® Inj. or to the ingredients of Synovian® Inj. * A patient with infection at the joint * A patient with skin infection or skin disease at the injection area * A patient diagnosed with osteoarthritis with the Kellgren & Lawrence Grade IV in X-ray within 12 months before enrollment of this study.

Design outcomes

Primary

Measure	Time frame	Description
safety endpoints	Week 2	injection site reactions

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026